127 related articles for article (PubMed ID: 25320353)
1. Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease.
Shiraishi T; Tamura Y; Taniguchi K; Higaki M; Ueda S; Shima T; Nagura M; Nakagawa T; Johnson RJ; Uchida S
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1313-22. PubMed ID: 25320353
[TBL] [Abstract][Full Text] [Related]
2. Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages.
Tamura Y; Tanabe K; Kitagawa W; Uchida S; Schreiner GF; Johnson RJ; Nakagawa T
Am J Physiol Renal Physiol; 2012 Aug; 303(3):F339-49. PubMed ID: 22622455
[TBL] [Abstract][Full Text] [Related]
3. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
5. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
[TBL] [Abstract][Full Text] [Related]
6. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
9. Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.
Kepecs DM; Yuen DA; Zhang Y; Thai K; Connelly KA; Gilbert RE
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638853
[TBL] [Abstract][Full Text] [Related]
10. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.
Husain K; Ferder L; Mizobuchi M; Finch J; Slatopolsky E
Am J Nephrol; 2009; 29(5):465-72. PubMed ID: 19033720
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
16. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury.
Rana I; Velkoska E; Patel SK; Burrell LM; Charchar FJ
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F943-54. PubMed ID: 26400542
[TBL] [Abstract][Full Text] [Related]
18. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
20. Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model.
Hamar P; Kerjaschki D
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H981-H990. PubMed ID: 27496878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]